Article Sidebar
Views pdf: 187
CLINICAL AND PATHOLOGY CHARACTERISTICS OF GASTRIC CARCINOMA STAGE II-IIIC UNDERGOING RADICAL SURGERY
Main Article Content
Abstract
Stomach cancer remains a disease with a poor prognosis. Clinical symptoms are often poor and vague. Diagnosis is mainly based on endoscopy and biopsy for histopathological examination. Purpose: To comment on some clinical and pathological characteristics of gastric cancer stage II - IIIC treated with radical surgery at K Hospital from January 2013 to December 2015. Methods: 109 gastric cancer patients after radical surgery were retrospectively reviewed the clinical and pathological characteristics. Results: Epigastric pain is the most common symptom, accounting for 88.1%. Tumors are mainly located in the lesser curvature (62.4%). The most common adenocarcinoma was 75.2%. The majority of patients are stage II, accounting for 56.9% (IIA: 26.6 and IIB: 30.3%). Conclusion: The status of lymph node metastasis tends to increase with the degree of invasion of the tumor tissue into the stomach wall (pT stage).
Article Details
Keywords
Gastric cancer, clinical symptom, histopathology.
References
2. Nguyễn Văn Hiếu (2010), Ung thư dạ dày, Điều trị phẫu thuật bệnh ung thư, Nhà xuất bản Y học, 2010, 256-268.
3. Bang YJ, Van Custem E, Feyereislova A et al (2010), Phase III Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial, Lancet, 2010; 376: 687–97.
4. Trịnh Hồng Sơn (2001), Nghiên cứu nạo vét hạch trong điều trị phẫu thuật ung thư dạ dày, Luận án tiến sỹ Y khoa, Trường Đại học Y Hà Nội.
5. Vũ Quang Toản (2016). Đánh giá kết quả điều trị ung thư dạ dày giai đoạn IIB-III (T4, N0-3, M0) bằng hóa chất bổ trợ EOX sau phẫu thuật tại bệnh viện K. Luận án Tiến sĩ Y học. Trường Đại học Y Hà Nội, 2016.
6. Nguyễn Thị Vượng (2013). Đánh giá hiệu quả phác đồ XELOX trong điều trị bổ trợ ung thư dạ dày. Luận án Thạc sĩ Y học. Trường Đại học Y Hà Nội, 2013.
7. Y. J. Bang và các cộng sự. (2012), "Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial", Lancet. 379 (9813), tr. 315-21.